Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Loading...
Community
/
United States
/
Healthcare
/
Electromed
Create a narrative
Electromed Community
NYSEAM:ELMD Community
3
Narratives
written by author
0
Comments
on narratives written by author
10
Fair Values set
on narratives written by author
Community Investing Ideas
Electromed
Popular
Undervalued
Overvalued
Electromed
AN
AnalystHighTarget
Community Contributor
Rising Home Healthcare Trends Will Unlock New Market Opportunity
Key Takeaways Hospital channel expansion and rising disease awareness are set to compound revenue growth beyond incremental analyst forecasts, tapping into a much larger addressable market. Direct-to-patient focus, supply chain optimization, and sales force leverage are expected to drive sustained margin outperformance and long-term earnings expansion.
View narrative
US$38
FV
36.3% undervalued
intrinsic discount
9.53%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
18 days ago
author updated this narrative
Electromed
AN
AnalystConsensusTarget
Based on Analyst Price Targets
Bronchiectasis Awareness And Home Care Will Drive Lasting Success
Key Takeaways Increased awareness and industry campaigns are expected to boost diagnosis and treatment rates, driving sustained growth and expanded market share. Digital investments, expanded sales force, and operational improvements will enhance productivity, margins, and efficiency, supporting ongoing revenue and earnings growth.
View narrative
US$35
FV
30.9% undervalued
intrinsic discount
9.01%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
24 days ago
author updated this narrative
Electromed
AN
AnalystLowTarget
Community Contributor
Concentrated Respiratory Care Will Face Hurdles While Sustaining Modest Promise
Key Takeaways Heavy reliance on a narrow product focus and limited market expansion could threaten growth if innovation or reimbursement environments shift. Rising costs and increasing competition may outpace revenue gains, creating long-term challenges for sustaining margins and earnings growth.
View narrative
US$29
FV
16.6% undervalued
intrinsic discount
8.32%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 1 month ago
author updated this narrative